DarioHealth Corp. (DRIO) financial statements (2021 and earlier)
Company profile
| Business Address |
8 HATOKHEN ST. CAESAREA, 38900 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 20 | 11 | 4 | 1 | 3 | 2 | 2 | ||
| Cash and cash equivalents | 20 | 11 | 4 | 1 | 3 | 1 | 2 | ||
| Short-term investments | 0 | 0 | 0 | 0 | 0 | ||||
| Restricted cash and investments | 0 | 0 | 0 | ||||||
| Receivables | 0 | 0 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 1 | 1 | 1 | 1 | 1 | 0 | ✕ | ||
| Inventory | 1 | 1 | 1 | 1 | 1 | 0 | |||
| Prepaid expense | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||
| Deferred costs | 0 | 0 | |||||||
| Other current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other undisclosed current assets | 1 | 0 | 0 | 0 | |||||
| Total current assets: | 23 | 13 | 6 | 3 | 4 | 2 | 3 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Deposits noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other undisclosed noncurrent assets | 0 | ||||||||
| Total noncurrent assets: | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| TOTAL ASSETS: | 25 | 14 | 7 | 4 | 5 | 3 | 4 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4 | 4 | 3 | 3 | 2 | 2 | 1 | ||
| Accounts payable | 2 | 3 | 2 | 2 | 1 | 1 | |||
| Accrued liabilities | 1 | 1 | 0 | 1 | 0 | 1 | 1 | ||
| Employee-related liabilities | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||
| Deferred revenue | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 0 | ||||||||
| Deferred revenue and credits | ✕ | ✕ | 0 | ||||||
| Other undisclosed current liabilities | 1 | 0 | 1 | ||||||
| Total current liabilities: | 5 | 5 | 3 | 3 | 2 | 2 | 2 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 0 | ||||||||
| Operating lease, liability | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 0 | 7 | 3 | 4 | |||||
| Derivative instruments and hedges, liabilities | 0 | 7 | 3 | 4 | |||||
| Total noncurrent liabilities: | 0 | 0 | 7 | 3 | 4 | ||||
| Total liabilities: | 6 | 5 | 3 | 10 | 4 | 6 | 2 | ||
| Temporary equity, carrying amount | 2 | 3 | |||||||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 19 | 9 | 4 | (7) | (2) | (5) | (0) | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Additional paid in capital | 129 | 98 | 75 | 48 | 42 | 31 | 20 | ||
| Accumulated deficit | (110) | (89) | (71) | (55) | (43) | (36) | |||
| Other undisclosed stockholders' equity attributable to parent | (20) | ||||||||
| Total stockholders' equity: | 19 | 9 | 4 | (7) | (2) | (5) | (0) | ||
| Other undisclosed liabilities and equity | 3 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 25 | 14 | 7 | 4 | 5 | 3 | 4 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 8 | 7 | 5 | 3 | 1 | 0 | ||
| Cost of revenue | (5) | (6) | (4) | (4) | (2) | (2) | ||
| Cost of goods and services sold | (5) | (6) | (4) | (4) | (0) | (1) | ||
| Other undisclosed gross profit | (0) | |||||||
| Gross profit: | 3 | 2 | 1 | (1) | (1) | (3) | ||
| Operating expenses | (20) | (19) | (16) | (10) | (7) | (9) | (14) | |
| Other operating expense, net (Other Expenses) | (0) | |||||||
| Other undisclosed operating income | 0 | |||||||
| Operating loss: | (18) | (18) | (14) | (11) | (8) | (11) | (14) | |
| Nonoperating income (expense) | (0) | (0) | (1) | 0 | 1 | (2) | (0) | |
| Other nonoperating expense | (0) | (0) | (0) | (0) | (0) | (4) | (0) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 14 | 26 | 28 | |||||
| Net income (loss): | (18) | (18) | (16) | (11) | 7 | 13 | 14 | |
| Other undisclosed net loss attributable to parent | (14) | (26) | (28) | |||||
| Net loss attributable to parent: | (18) | (18) | (16) | (11) | (7) | (13) | (14) | |
| Preferred stock dividends and other adjustments | (0) | (3) | ||||||
| Other undisclosed net loss available to common stockholders, basic | (3) | (0) | (0) | (0) | (0) | (0) | ||
| Net loss available to common stockholders, diluted: | (21) | (18) | (16) | (12) | (7) | (16) | (14) | |
Comprehensive Income ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (18) | (18) | (16) | (11) | 7 | 13 | 14 | |
| Comprehensive income (loss): | (18) | (18) | (16) | (11) | 7 | 13 | 14 | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (28) | |||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (18) | (18) | (16) | (11) | 7 | 13 | (14) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.